SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009794
Filing Date
2022-05-13
Accepted
2022-05-13 07:32:55
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20220331.htm   iXBRL 10-Q 1431423
2 EX-31.1 hcwb-ex31_1.htm EX-31.1 16635
3 EX-31.2 hcwb-ex31_2.htm EX-31.2 16770
4 EX-32.1 hcwb-ex32_1.htm EX-32.1 12298
5 EX-32.2 hcwb-ex32_2.htm EX-32.2 11953
  Complete submission text file 0000950170-22-009794.txt   4438492

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20220331.xsd EX-101.SCH 27571
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20220331_lab.xml EX-101.LAB 249690
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20220331_pre.xml EX-101.PRE 184901
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hcwb-20220331_cal.xml EX-101.CAL 26753
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hcwb-20220331_def.xml EX-101.DEF 123476
41 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20220331_htm.xml XML 624316
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 22920249
SIC: 2834 Pharmaceutical Preparations